Annual Report - FY12-13 Download. Annual Report - FY11-12 Download. Annual Report - FY10-11 Hon'ble High Court of Hyderabad approved the merger of Auctus Pharma with Granules India : 13-11-2014: Download: Unpaid Dividend FY 2012-13. Download. Unpaid Dividend FY 2013-14. Download. Unpaid QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) 2011 was derived from the Company's audited consolidated financial statements included in the 2011 Annual Report on Form 10-K. On February 17, 2012, through Par Pharmaceutical, Inc., our wholly-owned subsidiary, we completed our RSS stands for Really Simple Syndication. RSS feed is a XML file that provides summaries, including links to the full versions of the content.It is available through RSS feed reader or through some browsers. Sun Pharma Inds. Live BSE, NSE Charts, historical charts, F&O Quote, Stock quote of Sun Pharma Inds., Sun Pharma Inds. News, Videos, Stock Market Reports, capitalisation, financial report, volume Striving for Leadership through Chemistry. We are using cookies to give you the best experience on our website. Accept 2012-13_Annual_Report-SPIL. Internal controls sun pharmas defined organizational Lab Report. Uploaded By Professor_Moon_Dragon15. Pages 132 This preview shows pages 33-37. Sign up to view the full content. INTERNAL CONTROLS Sun Pharmaceuticals Industries Ltd. (SUNPHARMA) - Raw Materials Company raw materials « Mar 11 Mar 13 » Rediff MoneyWiz, the personal finance service from Rediff.com equips the user with tools and information in the form of graphs, charts, expert advice, and more to stay up-to-date and make informed decisions. Sun Pharmaceutical Industries's annual revenues are over $500 million (see exact revenue data) and has over 1,000 employees. It is classified as operating in the Pharmaceutical & Medicine Manufacturing industry. It is a broadly described annual report of Sun Pharmaceutical Industries Limited in the year of 2013-2014.During the financial year,